Insulin degludec in clinical practice: type 1 diabetes patients switched from their basal insulin to insulin degludec

Blanquez Martinez David; Hayon Ponce Maria; Caballero Romero Alvaro; Diaz Villamarin Xando; Nieto Gomez Pelayo; Moron Romero Rocio; Davila Fajardo Cristina

首页> 外文期刊>International journal of clinical pharmacy. >Insulin degludec in clinical practice: type 1 diabetes patients switched from their basal insulin to insulin degludec

【24h】

Insulin degludec in clinical practice: type 1 diabetes patients switched from their basal insulin to insulin degludec

机译：胰岛素Degludec在临床实践中：1型糖尿病患者从其基础胰岛素转换为胰岛素Degledec

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《International journal of clinical pharmacy.》 |2018年第1期|共2页
作者
Blanquez Martinez David; Hayon Ponce Maria; Caballero Romero Alvaro; Diaz Villamarin Xando; Nieto Gomez Pelayo; Moron Romero Rocio; Davila Fajardo Cristina;
展开▼
作者单位

Hosp Univ Campus Salud Farm Hosp Granada Spain;

Hosp Univ Campus Salud Endocrinol &

Nutr Granada Spain;

Hosp Univ Campus Salud Farm Hosp Granada Spain;

Hosp Univ Campus Salud Farm Hosp Granada Spain;

Hosp Univ Campus Salud Farm Hosp Granada Spain;

Hosp Univ Campus Salud Farm Hosp Granada Spain;

Hosp Univ Campus Salud Farm Hosp Granada Spain;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词

相似文献

外文文献
中文文献
专利

1. Insulin degludec in clinical practice: type 1 diabetes patients switched from their basal insulin to insulin degludec [J] . Blanquez Martinez David, Hayon Ponce Maria, Caballero Romero Alvaro, International journal of clinical pharmacy. . 2018,第1期

机译：胰岛素Degludec在临床实践中：1型糖尿病患者从其基础胰岛素转换为胰岛素Degledec
2. Clinical outcomes in real‐world patients with type 2 diabetes switching from first‐ to second‐generation basal insulin analogues: Comparative effectiveness of insulin glargine 300 units/mL and insulin degludec in the DELIVER D+ cohort study [J] . Sullivan Sean D., Bailey Timothy S., Roussel Ronan, Diabetes, obesity & metabolism . 2018,第9期

机译：现实世界患者的临床结果来自第一至第二代基底胰岛素类似物的2型糖尿病切换：胰岛素狼犬300单位/ ml和胰岛素Degludec的比较有效性在递送D +队列研究中
3. Basal and Bolus Insulin Dose Changes after Switching Basal Insulin to Insulin Degludec in Patients with Type 1 Diabetes Mellitus: A Pilot Study [J] . Hamamoto Yoshiyuki, Honjo Sachiko, Fujimoto Kanta, Clinical drug investigation . 2017,第9期

机译：在1型糖尿病患者中切换基底胰岛素到胰岛素Degludec的基础和推注胰岛素剂量变化：试验研究
4. Switching to insulin glargine 300 U/mL from other basal insulin analogues provides less 24-hour glucose variability in hospitalized patients with type 1 diabetes [C] . V.V. Klimontov, E.A. Koroleva, O.N. Fazullina International Multiconference Bioinformatics of Genome Regulation and StructureSystems Biology . 2018

机译：从其他基础胰岛素类似物转换为甘精胰岛素300 U / mL可使住院的1型糖尿病患者的24小时葡萄糖变异性降低
5. Evaluating Hypoglycemic Risk of Two Basal Insulin Delivery Methods for Type 1 Diabetes: A Comparison of Tresiba Insulin Against Continuous Subcutaneous Insulin Infusion Using Data from Continuous Glucose Monitors [D] . Lane, Benjamin. 2020

机译：评估1型糖尿病两种基础胰岛素递送方法的低血糖风险：使用来自连续葡萄糖监测器的数据进行TRESIBA胰岛素对连续皮下胰岛素输注的比较
6. A 1‐year prospective observational study of Japanese outpatients with type 1 and type 2 diabetes switching from insulin glargine or detemir to insulin degludec in basal–bolus insulin therapy (Kumamoto Insulin Degludec Observational study) [O] . Seiya Shimoda, Miki Sato, Taiji Sekigami, 2016

机译：一项为期1年的前瞻性观察性研究针对日本的1型和2型糖尿病患者在基础推注胰岛素治疗中从甘精胰岛素或地特米尔胰岛素转为地格列酮胰岛素（熊本Insulin Degludec观察性研究）
7. Clinical outcomes in real-world patients with type 2 diabetes switching from first- to second-generation basal insulin analogues: Comparative effectiveness of insulin glargine 300 units/mL and insulin degludec in the DELIVER D+ cohort study [O] . Sean D. Sullivan, Timothy S. Bailey, Ronan Roussel, 2018

机译：现实世界患者的临床结果来自第一至第二代基底胰岛素类似物的2型糖尿病切换：在递送D +队列研究中的胰岛素狼蛛300个单位/ ml和胰岛素Degludec的比较有效性

Insulin degludec in clinical practice: type 1 diabetes patients switched from their basal insulin to insulin degludec

著录项

相似文献

相关主题

期刊订阅